Pharmacy

Although there were fewer drug shortages at the end of 2017, the number of shortages has been growing, according to a recent FDA report.

GoodRx, a health tech startup that helps the uninsured buy medications at lower costs, is looking to sell itself for anywhere between $1.5 billion and $3 billion, sources told CNBC.

Becker's Hospital Review has reported the following drug company layoffs in 2018. They are listed below, beginning with the most recent.

Purdue Pharma, the embattled OxyContin maker, laid off the remaining members of its sales force June 19, as it shifts its focus away from opioids and pursues cancer and central nervous disorder medications, according to the Stamford Advocate.

Reputation Institute released its annual survey of the most reputable pharmaceutical companies.

As disruptors continue to push into the healthcare arena and pressure accumulates to reduce drug prices, pharmaceutical companies are taking steps to remain competitive and enhance their drug pipelines.

Citing a contract dispute, Express Scripts is threatening to strip CareZone, a startup that delivers medications to customers, from its network, CNBC reports.

Pharmaceutical giant Roche Holding will pay $2.4 billion to acquire the remaining shares it doesn't already own of Foundation Medicine, putting more stake into a future for personalized cancer treatments, according to The Wall Street Journal.

CVS Health will soon offer a delivery service for  prescription medications and some over-the-counter drugs, according to CNBC.

As direct-to-consumer genetic testing services continue to gain traction, the U.S. is beginning to see a "national shortage" of genetic counselors, according to The Atlantic.